International Alport Syndrome Meeting Report Published

KFOC, Pedersen Family and Partners award two new 2014 Alport Syndrome Research Grants

Dr. Adeera Levin Awarded Kidney Foundation of Canada’s 2014 Medal for Research Excellence

First Nations Adults with Diabetes Have More than Double the Risk of End-Stage Kidney Disease

Dr. Marcello Tonelli Awarded 2013 Medal for Research Excellence for Changing Nephrology Practice in Canada and Beyond

Paying Living Kidney Donors May Be Cost-Effective and Help Prolong Lives

The Kidney Foundation congratulates Dr. Andreas Laupacis on being awarded the inaugural CIHR Barer-Flood Prize in Health Services and Policy Research

New Research to Discover a Cure for Rare Kidney Disease

CSN Announces Editor in Chief of New Journal

Dr. Adeera Levin appointed President of the International Society of Nephrology

Sugary Drinks May Increase Risk of Kidney Stones

Launch of new Canadian National Transplant Research Program

Alberta Researchers Receive Top Achievement in Health Research Award

Kidney Foundation of Canada Helps Fund World’s First Gene Therapy Clinical Trial for Fabry Disease

First-of-Its-Kind Canadian Project to Chart the Future of Dialysis Research

Lead Investigator on Landmark Walkerton Health Study Awarded 2012 Medal for Research Excellence

New Drug Shows Hope for ADPKD Treatment

New Findings Debunk Long-Held Theory that Kidney Disease is Part of the Normal Aging Process

The Kidney Foundation of Canada partners with Kidney Cancer Canada and Government to support national research network

Thu, 15 Nov 2012

Lead Investigator on Landmark Walkerton Health Study Awarded 2012 Medal for Research Excellence

November 15, 2012 – Dr. William Clark, the lead investigator of Canada’s landmark Walkerton Health Study, has been awarded the 2012 Kidney Foundation of Canada Medal for Research Excellence. Distinguished in many areas of medicine and nephrology, Dr. Clark has gained international recognition for his observational studies, randomized clinical trials and treatment of kidney patients. Most recently, he has gained world-wide attention for his work examining the increased risks of initiating dialysis treatment early.

Dr. Clark’s career as a clinician-scientist spans over three decades. He has focused on studies aimed at preventing or slowing progressive kidney disease. His work has explored many issues, including the role of platelets in kidney injury resulting from diseases of the immune system such as lupus nephritis or glomerulonephritis. He also studied the application of plasma (blood) exchange and dialysis to improve the treatment and health of people suffering from kidney injury.  

“Dr. Clark is frequently consulted to develop protocols for identification, management and follow-up of persons exposed to contaminated water,” says Dr. Louise Moist, Professor of Medicine at the Schulich School of Medicine University of Western Ontario. “The body of literature created from the Walkerton Health Study will provide ongoing evidence of the need for screening to identify the health risks after such an outbreak and ways to prevent severe impacts through early treatment.”

Currently, Dr. Clark is initiating a randomized control trial that will assess the role of increased water intake on slowing the progression of the loss of kidney function in patients suffering from chronic kidney disease. It is based on his 7 year longitudinal study in Walkerton. He is Co-chair of the Canadian Society of Nephrology’s guidelines committee on early initiation of dialysis and of the Research Council of The Kidney Foundation of Canada.

Dr. Clark was recently awarded the Queen Elizabeth Diamond Jubilee Medal for his charitable work, which notably includes initiating and managing two different major fundraisers as well as being Honorary Cabinet Member (Ontario) of The Kidney Foundation’s New Challenge Campaign.

For more details on Dr. William Clark's career visit

Download the full press release